2013 American Transplant Congress
Clinical Outcome of Living Donor Liver Transplantation in Patient with Hepatocellular Carcinoma and Impact to the Various Criteria
Surgery, Seoul St.Mary's Hospital, Catholic University of Korea, Seoul, Republic of Korea
Purpose: Liver transplantation (LT) as treatment for hepatocellular carcinoma (HCC) is known to be the best therapeutic option. To obtain good result, it is important…2013 American Transplant Congress
Echocardiographic Changes in Nondiabetic Kidney Transplant Recipients after Conversion from a Calcineurin Inhibitor to an Anti-mTOR Drug
Morphological and functional changes in the heart are associated with a high degree of morbidity and mortality after a kidney transplant. Anti-mTOR drugs may revert…2013 American Transplant Congress
Evolution in Kidney Transplant Recipients of the Expression of Skin-Homing Receptors in the Different CD4+ T Cell Subsets Obtained by Aspiration Cytology of the Renal Graft Versus Peripheral Blood
Monitoring the CD4+ T cell subsets, including the Treg cells (CD4 CD25highCD127low) and the conventional CD4+ T cells (CD127highCD25low), may help optimize the management of…2013 American Transplant Congress
Fine Needle Aspiration Cytology and Detection of Lymphocyte Subsets in Kidney Transplant Patients Receiving Induction with Basiliximab or Thymoglobulin: Impact on Kidney Function
Induction therapy with basiliximab or thymoglobulin after kidney transplantation modifies the expression of lymphocyte subsets, including the Treg cells (CD127lowCD25high). Though this may influence the…2013 American Transplant Congress
One-Shot Versus Standard Perioperative Antibiotic Prophylaxis after Kidney Transplantation: Results from a Prospective Randomized Multicenter Study
Background. After kidney transplantation (KT), infections represent one of the main complications. The use of appropriate antibiotics (AB) should be optimized in order to avoid…2013 American Transplant Congress
Alemtuzumab Induction with Tacrolimus Monotherapy vs TAC+MMF Bitherapy in Pancreas Transplant Recipients: 10 Year Experience
Surgery, Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
PURPOSE: We report our pancreas transplantation experience with alemtuzumab (Campath-1H) induction with tacrolimus monotherapy vs. tacrolimus plus mycophenolate mofetil (MMF) bitherapy with respect to 10…2013 American Transplant Congress
699 Living Donor Kidney Transplants Using Alemtuzumab Pretreatment and Tacrolimus Monotherapy: 10 Year Experience
Surgery, Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
We analyzed our 10-year experience with Alemtuzumab (Campath-1H) induction and tacrolimus monotherapy for living donor kidney transplants (LDKT).We performed 699 consecutive unselected LDKT from 12/11/2002…2013 American Transplant Congress
1025 Deceased Donor Kidney Transplants Using Alemtuzumab Pretreatment and Tacrolimus Monotherapy: 10 Year Experience
Surgery, Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
We analyzed our 10-year experience with Alemtuzumab (Campath-1H) induction and tacrolimus monotherapy for deceased donor kidney transplants (DDKT).We performed 1025 consecutive unselected DDKT from 12/05/2002…2013 American Transplant Congress
Efficacy and Safety of Renin Angiotensin Aldosterone System (RAAS) Blockade Immediately after Renal Transplantation
Aim: A strong pathophysiological rationale underpins the use of RAAS blockers in renal transplant recipients. Nevertheless, transplant physicians are reluctant to use these drugs, due…2013 American Transplant Congress
Fracture Risk in Kidney Transplant Recipients: A Systematic Review
Background: Skeletal fractures increase morbidity and mortality in kidney transplant recipients yet the incidence and risk factors for fracture in recipients remains uncertain. We conducted…
American Transplant Congress abstracts